MJardin Group Announces Fourth Quarter and Full Year 2018 Financial Results DENVER and TORONTO, May 07, 2019 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR)...
Vancouver, B.C. / TheNewswire / May 7, 2019 – HERITAGE CANNABIS HOLDINGS CORP. (CSE:CANN) (the “Company” or “Heritage”) is pleased to announce that it has closed its previously announced...
GrowGeneration Reports Record Q1 2019 Revenues and Net Income Increases Guidance to $60M-$65M and $.14-$.18 Adjusted EBITDA DENVER, May 7, 2019 /PRNewswire/ – GrowGeneration Corp. (OTCQX: GRWG), (“GrowGen” or...
TerrAscend Announces Books Closed on Over-Subscribed US$52 Million Private Placement TORONTO, May 7, 2019 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) has successfully completed the book-build for...
Canopy Growth Introduces Spectrum Therapeutics SMITHS FALLS, ON, May 7, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new...
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO, May 07, 2019 (GLOBE NEWSWIRE)...
Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing TORONTO, May 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2019 Epidiolex U.S. Q1 net sales of $33.5m Positive Phase 3 pivotal results...
Cansortium Awarded Cannabis Cultivation, Processing and Medical Sales License by Health Canada Miami, Florida–(Newsfile Corp. – May 6, 2019) – Cansortium Inc. (CSE: TIUM) (the “Company” or “Cansortium”), a...
Curaleaf Acquires Rights to Cultivation and Processing Capacity in Ohio Enters attractive Ohio market and plans for vertical integration in the state WAKEFIELD, Mass., May 6, 2019 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA)...
NIC Inc. Acquires Denver-based Complia Acquisition expands NIC’s licensing expertise with a new technology platform exclusively for government regulation of cannabis and hemp industries OLATHE, Kan.–(BUSINESS WIRE)–NIC Inc. (Nasdaq:...
This is a copy of the May 5th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, While mainstream companies are in the thick...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
Exclusive Interview with Cellibre Founder and CEO Ben Chiarelli Cannabinoid biosynthesis is an emerging technology that holds the promise of producing THC, CBD, and other cannabinoids at a fraction...
After a 57.4% rebound in Q1, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up some ground in April, declining 1.5%: The index, which had 64 qualifying...
Valens Announces Acceleration of Warrant Expiry Date KELOWNA, BC, May 2, 2019 /CNW/ – Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF) (the “Company” or “Valens”), a multi-licensed, vertically integrated...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index backtracked marginally in April, declining 0.9% to 1081.95: The index remains substantially below the all-time closing high of 1289.57 on October...
CannTrust Announces Pricing of Public Offering of Common Shares VAUGHAN, ON, May 2, 2019 /PRNewswire/ – CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX:TRST,NYSE:CTST) announced today the pricing of...
TerrAscend to be the First and Only Cannabis Company with Sales in the US, Canada, and Europe TerrAscend Canada receives EU GMP certification, announces distribution agreement with German partner Will...
Canopy Growth Acquires Germany’s C3 Cannabinoid Compound Company Founded by top global herbal medicine manufacturer Bionorica SE, C3 is a leader in cannabinoid-based medical therapies used by European physicians to...
